Publicacións en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (18)

2022

  1. Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266

2018

  1. Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: A nationwide proficiency study

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 3, pp. 692-697

2017

  1. Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme

    PLoS ONE, Vol. 12, Núm. 3

  2. Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing

    Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY

2016

  1. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

2015

  1. Rates of faecal colonization by carbapenemase-producing enterobacteriaceae among patients admitted to ICUs in Spain

    Journal of Antimicrobial Chemotherapy

2014

  1. Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 10, pp. 2629-2633

  2. Epidemiologic and clinical impact of acinetobacter baumannii colonization and infection: A reappraisal

    Medicine (United States), Vol. 93, Núm. 5, pp. 202-210

  3. Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 11, pp. 3119-3126

  4. Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): Experience from the RESITRA-REIPI cohort

    Transplant Infectious Disease, Vol. 16, Núm. 3, pp. 387-396

2012

  1. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort

    Transplant Infectious Disease, Vol. 14, Núm. 6, pp. 595-603

  2. Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: A prospective and multicentre cohort study

    Transplant International, Vol. 25, Núm. 12, pp. 1275-1281

2010

  1. Immunosuppressive therapy and infection after kidney transplantation

    Transplant Infectious Disease, Vol. 12, Núm. 5, pp. 397-405

2009

  1. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the resitra (spanish network of infection in transplantation) cohort

    Clinical Infectious Diseases, Vol. 48, Núm. 12, pp. 1657-1665

2008

  1. Donor infection and transmission to the recipient of a solid allograft

    American Journal of Transplantation, Vol. 8, Núm. 11, pp. 2420-2425

  2. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation

    Clinical Infectious Diseases, Vol. 47, Núm. 7, pp. 875-882

  3. Incisional surgical infection in heart transplantation

    Transplant Infectious Disease, Vol. 10, Núm. 4, pp. 298-302

2007

  1. Pneumonia after lung transplantation in the resitra cohort: A multicenter prospective study

    American Journal of Transplantation, Vol. 7, Núm. 8, pp. 1989-1996